Rosetrees is a private UK charity
Rosetrees is a private UK charitySupporting cutting edge medical research for more than 30 years.
The aim is to improve the health and wellbeing of society.
Currently, around 300 projects are supported, from seedcorn 'out of the box' research ideas to large awards, many with co-funders.
The focus is on testing new ideas across the spectrum of medical research to bring the earliest patient benefit.
Our Philosophy
We use a venture philanthropy approach to promote new ideas. We fund initial seedcorn grants to generate preliminary data that can result in further funding. We also fund larger projects and interdisciplinary grants.
Our Research
Our over-arching goal is to fund research in all areas of medicine that will benefit human health and well-being within 5-10 years.
Rosetrees Team
Rosetrees is run by a small, highly skilled and dedicated team.
Scientific Advisory Panel
We are advised by a panel of world-leading, internationally renowned scientists.
Grant Schemes
We have a number of different grant schemes available, from small seedcorn awards to major project grants.
Keep up to date with Rosetrees latest news
Excited to announce Tim Eisen will speak at our interdisciplinary workshop Tackling #DrugResistance in Cancer next January on developing therapies & clinical translation to address #TumourResistance.
Register now: http://bit.ly/3NozDCH
@Cambridge_Uni | @AstraZeneca
A new study led by Rosetrees-funded scientists at UCL Queen Square Institute of Neurology has identified the molecular defects underlying a rare and complex developmental brain condition in children (Autosomal Recessive ACBD6-related disorder).
@UCLIoN
Celebrating #thisisengineering @QMULSEMS industry event with #bioengineers healing wounds in fetal skin, joints and membranes.
Save lives together with @QMULSciEng @QMULBartsTheLon
Funded by @RosetreesT @GOSHCharity @EPSRC @PrenatalTherapy @PpromAwarenessU
Applications are invited for Rosetrees intermediate/major project grants (up to 100k/210k over 3 years respectively) to support innovative biomedical research projects, with established proof of concept, that have the potential for clinical translation.